Global Antifungal Drugs Market Report By Drug Type (Echinocandins, Azoles, Polyenes, Allylamines), By Therapeutic Indications (Aspergillosis, Dermatophytosis, Candidiasis, Others), By Dosage Forms (Powders,Ointments,Drugs,Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11214197
February 2021
Report Formats:

The global demand for Antifungal Drugs Market is presumed to reach the market size of nearly USD XXX MN by 2027 from USD XXX MN in 2020 with a CAGR of X.XX% under the study period 2021 - 2027.

Antifungal drugs refer to a pharmaceutical fungicide primarily used to treat many infections like candidiasis, ringworms, athletes' feet, and others. These drugs can easily be purchased through a doctor’s prescription, whereas some are available over the counter. Fungal infections arise due to organism feed by breaking down the living tissues, also known as dermatophytes. They can utilize keratin protein and cause infection over hair, skin, and nails. The only purpose of these drugs is to inhibit the fungal cell from growing by making the cell’s content break out. An unhygienic environment may drive to a severe condition in causing an infection on the skin.

Market Dynamics

The growth of this market can be attributed to rising awareness about the products’ availability through online advertisement along with a wide range of products. In addition to this, increasing occurrences of immunological diseases and changing environmental conditions, and the rise in the spread of many infectious diseases from individual to individual are also boosting the demand. A rising number of fungal infections like aspergillosis and candidiasis are also upsurging the demand during the forecast period. However, the availability of substitute is hindering the market growth. At the same time, the adoption of advanced technologies in manufacturing many drugs and providing effective treatment procedures for diverse infectious diseases globally is ready to create a new avenue for market growth in the coming years.

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of antifungal drugs. The growth and trends of antifungal drugs industry provide a holistic approach to this study. 

Market Segmentation

This section of the antifungal drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Drug Type

  • Echinocandins
  • Azoles
  • Polyenes
  • Allylamines
By Therapeutic Indications
  • Aspergillosis
  • Dermatophytosis
  • Candidiasis
  • Others
By Dosage Forms
  • Powders
  • Ointments
  • Drugs
  • Others
Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Antifungal Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Antifungal Drugs Market Share by Region (Representative Graph)

Global Antifungal Drugs Market Share


The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the antifungal drugs market include Pfizer Inc., Sanofi S.A., Gilead Sciences, Inc., Merck & Co., Inc., Novartis International AG, Abbott Laboratories, Bayer AG, Scynexis Inc., Enzon Pharmaceuticals, Inc., and GlaxoSmithKline Plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
 
METHODOLOGY:

This market research report has been produced by gathering information based on primary and secondary research. Secondary research has been done using various sources, including (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. Additionally, our team conducts extensive primary research with key industry participants to gather first-hand data. The data is then analyzed and validated by industry experts.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . ANTIFUNGAL DRUGS – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Drug Type
           3.7.2 By Therapeutic Indications
           3.7.3 By Dosage Forms
           3.7.4 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL ANTIFUNGAL DRUGS MARKET ANALYSIS BY DRUG TYPE
       6.1 Overview by Drug Type
       6.2 Historical and Forecast Data
       6.3 Analysis by Drug Type
       6.4 Echinocandins Market by Regions
       6.5 Azoles Market by Regions
       6.6 Polyenes Market by Regions
       6.7 Allylamines Market by Regions
 
7 . GLOBAL ANTIFUNGAL DRUGS MARKET ANALYSIS BY THERAPEUTIC INDICATIONS
       7.1 Overview by Therapeutic Indications
       7.2 Historical and Forecast Data
       7.3 Analysis by Therapeutic Indications
       7.4 Aspergillosis Market by Regions
       7.5 Dermatophytosis Market by Regions
       7.6 Candidiasis Market by Regions
       7.7 Others Market by Regions
 
8 . GLOBAL ANTIFUNGAL DRUGS MARKET ANALYSIS BY DOSAGE FORMS
       8.1 Overview by Dosage Forms
       8.2 Historical and Forecast Data
       8.3 Analysis by Dosage Forms
       8.4 Powders Market by Regions
       8.5 Ointments Market by Regions
       8.6 Drugs Market by Regions
       8.7 Others Market by Regions
 
9 . GLOBAL ANTIFUNGAL DRUGS MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview, Historic and Forecast Data
           9.3.2. North America By Segment
           9.3.3. North America By Country
           9.3.4. United State
           9.3.5. Canada
           9.3.6. Mexico
       9.4. Europe
           9.4.1. Overview, Historic and Forecast Data
           9.4.2. Europe by Segment
           9.4.3. Europe by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7. Italy
           9.4.8. Russia
           9.4.9. Rest Of Europe
       9.5. Asia Pacific
           9.5.1. Overview, Historic and Forecast Data
           9.5.2. Asia Pacific by Segment
           9.5.3. Asia Pacific by Country
           9.5.4. China
           9.5.5. India
           9.5.6. Japan
           9.5.7. South Korea
           9.5.8. Australia
           9.5.9. Rest Of Asia Pacific
       9.6. Latin America
           9.6.1. Overview, Historic and Forecast Data
           9.6.2. Latin America by Segment
           9.6.3. Latin America by Country
           9.6.4. Brazil
           9.6.5. Argentina
           9.6.6. Peru
           9.6.7. Chile
           9.6.8. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview, Historic and Forecast Data
           9.7.2. Middle East & Africa by Segment
           9.7.3. Middle East & Africa by Country
           9.7.4. Saudi Arabia
           9.7.5. UAE
           9.7.6. Israel
           9.7.7. South Africa
           9.7.8. Rest Of Middle East And Africa
 
10 . COMPETITIVE LANDSCAPE OF THE ANTIFUNGAL DRUGS COMPANIES
       10.1. Antifungal Drugs Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF ANTIFUNGAL DRUGS INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Pfizer Inc.
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Sanofi S.A.
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Gilead Sciences, Inc.
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Merck & Co., Inc.
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Novartis International AG
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. Abbott Laboratories
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. Bayer AG
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Scynexis Inc.
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. Enzon Pharmaceuticals, Inc.
           11.11.1. Company Overview
           11.11.2. Financials
           11.11.3. Products
           11.11.4. Recent Developments
       11.12. GlaxoSmithKline Plc
           11.12.1. Company Overview
           11.12.2. Financials
           11.12.3. Products
           11.12.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Drug Type (USD MN)
  • Echinocandins Market by Geography (USD MN)
  • Azoles Market by Geography (USD MN)
  • Polyenes Market by Geography (USD MN)
  • Allylamines Market by Geography (USD MN)
  • Analysis Market by Therapeutic Indications (USD MN)
  • Aspergillosis Market by Geography (USD MN)
  • Dermatophytosis Market by Geography (USD MN)
  • Candidiasis Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis by Dosage Forms (USD MN)
  • Powders Market by Geography (USD MN)
  • Ointments Market by Geography (USD MN)
  • Drugs Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Antifungal Drugs Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of Antifungal Drugs Report
  • Market Research Process
  • Market Research Methodology
  • Global Antifungal Drugs Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Drug Type
  • Market Attractiveness Analysis by Therapeutic Indications
  • Market Attractiveness Analysis by Dosage Forms
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Drug Type (USD MN)
  • Echinocandins Market by Geography (USD MN)
  • Azoles Market by Geography (USD MN)
  • Polyenes Market by Geography (USD MN)
  • Allylamines Market by Geography (USD MN)
  • Global Market Analysis by Therapeutic Indications (USD MN)
  • Aspergillosis Market by Geography (USD MN)
  • Dermatophytosis Market by Geography (USD MN)
  • Candidiasis Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Dosage Forms (USD MN)
  • Powders Market by Geography (USD MN)
  • Ointments Market by Geography (USD MN)
  • Drugs Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials